AI / data analytics / healthtech / informatics

AI genomics concept
#AI / data analytics / healthtech / informatics #Biobanking #Genomics #Personalised medicine

Supercharging AI-drug discovery with strategic multiomic biobanks 

Niven R. Narain, PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market.   Artificial Intelligence (AI) has become a popular buzzword in the drug discovery and development lexicon but not all approaches to AI-driven… Read More

#Exclusive Content

AI clinical trials concept
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Clinical trial design #Clinical trials

Decoding diseases: The AI renaissance in clinical trials

Listen to this article on the DDW Podcast: Deepika Khedekar, Associate Centralized Clinical Lead at IQVIA, explains how artificial intelligence could make clinical trials more accurate, accessible and standardised. Over 19 million1 hearts succumb to cardiovascular disease yearly, while around 10 million2 lives are claimed by cancer every year. To put… Read More

#Exclusive Content

Antibodies
#AI / data analytics / healthtech / informatics #Antibodies #Antibody-based therapeutics #Artificial intelligence (AI) #Start-ups

Advancing antibody discovery with AI

Listen to this article on the DDW Podcast: DenovAI is the second start-up to launch from the global pharma consortium AION Labs -  an organisation that aims to improve the drug discovery and development process through the use of AI and other computational technologies. DDW Editor Reece Armstrong, speaks to Kashif… Read More

#Exclusive Content #Start-up Zone

Human cell
#AI / data analytics / healthtech / informatics #Gene expression #Metabolomics #Multi-omics #Omics #Spatial biology

What spatial biology can tell us about disease and drug discovery

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Benedikt Nilges, Head of Technology and Data Analytics at OMAPiX about spatial biology’s use in drug discovery and bettering our understanding of disease. RA: How does spatial biology enhance our understanding of the human body and associated… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Cloud computing #Drug discovery #Webinar

On-demand webinar: A data-driven approach to drug discovery

Watch this new webinar to embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. This on-demand webinar from Revvity Signals shows how cloud implementation fosters accessibility and collaboration, revolutionising research across locations and… Read More

Webinar date:
Brought to you by Revvity Signals
#News

#AI / data analytics / healthtech / informatics #Cloud computing #Drug discovery #Webinar

From lead optimisation to drug candidate triage: A data-driven approach to drug discovery

Embark on an in-depth journey through the pivotal Make-Test-Decide Workflow, where collaboration and data-driven decisions play a paramount role in the intricate landscape of drug discovery. This on-demand webinar shows how cloud implementation fosters accessibility and collaboration, revolutionising research across locations and companies. This presentation illustrates: The use of the… Read More

Webinar date:
Brought to you by Revvity Signals
#Webinars

#AI / data analytics / healthtech / informatics #Clinical trials #Imaging #Machine learning

Integration of AI in imaging clinical trials 

Sophie Winandy, Executive Director of Medical Imaging at ICON explores the benefits of AI and how it can be integrated throughout medical imaging within clinical trials.   Artificial intelligence (AI) is rapidly taking hold in the healthcare sector1, including in medical imaging, where AI often targets screening, patient eligibility, detection… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Clarivate #Machine learning

Seven AI drug discovery companies to watch

Seven companies have been highlighted in Clarivate’s ‘Companies to Watch Report’ for delivering more effective and safer medicines to market faster by leveraging artificial intelligence (AI) and machine learning (ML) technology. From identifying novel targets to simulating how drugs will function in the human body, Clarivate… Read More

#News #Trending News

#AI / data analytics / healthtech / informatics #Drug discovery #Generative AI #Webinar

Generative AI: Turning drug discovery into a technological pursuit

This webinar, supported by Thermo Fisher Scientific and presented by Generate:Biomedicines, is now available to view on-demand. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who will discuss how an integrated approach of using Cryo-EM with ML methods has the… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

#AI / data analytics / healthtech / informatics #Biotechnology #Drug development #Drug discovery #Technology

This week in drug discovery (11-15 September)  

News round-up for 11-15 September by DDW Digital Content Editor Diana Spencer. Spanning artificial intelligence, theranostics, radiopharmaceuticals, quantum simulation and small regulatory RNA, the top stories this week all cover cutting-edge technologies and techniques making a huge impact on modern drug discovery and development. Read More

#News

Future lab, AI and digital data
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Lab automation #Machine learning #Webinar

AI & Lab Automation: What are the key benefits and latest innovations?

In this webinar, hosted by DDW and co-sponsored by Benchling and Proscia, you will learn about the key benefits and latest innovations to be aware of in AI and lab automation. You will hear from Jeremy Skillington, CEO of Poolbeg Pharma, as well as sponsor presentations from Helen Liu-Mayo, Product… Read More

Webinar date:
Co-sponsored by Benchling and Proscia
#Webinars

AI brain
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Pharmaceutical industry

Pharma must embrace an AI future says new report

Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com. However, the change AI will bring about in drug discovery will take some time, according to the ‘Global Markets… Read More

#News #Trends & Analysis

#AI / data analytics / healthtech / informatics #Electronic Lab Notebooks (ELN) #Lab analytics #Lab of the future

You think you need an ELN… but are you asking the right questions?

Listen to this article on the DDW Podcast: Asks Matt Clifford, Director, Research and Innovation Strategy, IDBS. When it comes to technology transformations, sometimes finding the right solution comes from asking the wrong question. One 'wrong question' that I hear a lot is: "Is it time for our lab to invest… Read More

#Exclusive Content

Regulatory concept
#AI / data analytics / healthtech / informatics #Digitalisation #Drug development #Regulatory

Reflections on life science’s regulatory environment  

In this article, Amplexor asks some of the company’s closest industry partners and BE THE EXPERT event speakers for their views on the biggest developments in the Life Sciences Regulatory sphere over the last 12 months - and explore some of the most prominent themes and priorities seen throughout 2023.  … Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Cancer research #Genetics / genomics #Interview #Oncology #Sitting Down With

Sitting down with… Neil Dhawan

Listen to this article on the DDW Podcast: Reece Armstrong speaks to Neil Dhawan, the Co-founder and CEO of Totus Medicines about the company’s approach to drug discovery using fundamental technologies in chemistry, biology and artificial intelligence (AI). RA: How is Totus Medicines attempting to target untreatable or undruggable diseases? ND:… Read More

#Cancer Research #Exclusive Content

AI and genomics
#AI / data analytics / healthtech / informatics #DNA #Genetics / genomes #Precision medicine #Rare disease

New podcast on the future for genomics and big data

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “What’s the next step in big… Read More

#News